《RAS阻滞剂对高血压合并COVID-19患者临床特征的影响》勘误
Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.
作者信息
Huang Zheyong, Cao Jiatian, Yao Yumeng, Jin Xuejuan, Luo Zhe, Xue Yuan, Zhu Chouwen, Song Yanan, Wang Ying, Zou Yunzeng, Qian Juying, Yu Kaihuan, Gong Hui, Ge Junbo
机构信息
Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Critical Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
出版信息
Ann Transl Med. 2020 Sep;8(17):1119. doi: 10.21037/atm-2020-27.
Abstract
[This corrects the article DOI: 10.21037/atm.2020.03.229.].
摘要
[本文更正了文章的数字对象标识符：10.21037/atm.2020.03.229。]
相似文献
1
Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.《RAS阻滞剂对高血压合并COVID-19患者临床特征的影响》勘误
Ann Transl Med. 2020 Sep;8(17):1119. doi: 10.21037/atm-2020-27.
2
Erratum: Medicine, Volume 95, Issue 23: Erratum.勘误：《医学》，第95卷，第23期：勘误。
Medicine (Baltimore). 2016 Jul 18;95(28):e0916. doi: 10.1097/01.md.0000489580.04709.16. eCollection 2016 Jul.
3
Erratum: Medicine, Volume 95, Issue 24: Erratum.勘误：《医学》，第95卷，第24期：勘误。
Medicine (Baltimore). 2016 Aug 7;95(31):e5074. doi: 10.1097/01.md.0000490009.39850.74. eCollection 2016 Aug.
4
Erratum.勘误
Sci Technol Adv Mater. 2016 Apr 19;17(1):188. doi: 10.1080/14686996.2016.1176342. eCollection 2016.
5
Erratum.勘误
Heart Rhythm O2. 2021 Feb 19;2(1):111-112. doi: 10.1016/j.hroo.2020.12.001. eCollection 2021 Feb.
6
Erratum to: , Vol. 4.《……》第4卷勘误
Pilot Feasibility Stud. 2017 Oct 24;3:48. doi: 10.1186/s40814-017-0183-2. eCollection 2017.
7
Erratum: Publisher Correction to Volume 1 (2016).勘误：《第1卷（2016年）》的出版商更正。
EJNMMI Radiopharm Chem. 2018 Nov 26;3:13. doi: 10.1186/s41181-018-0049-9. eCollection 2018 Dec.
8
Erratum regarding previously published articles.关于先前发表文章的勘误。
JPRAS Open. 2021 Sep 24;30:176-177. doi: 10.1016/j.jpra.2021.09.008. eCollection 2021 Dec.
9
Erratum regarding previously published articles.关于先前发表文章的勘误。
Synth Syst Biotechnol. 2020 Oct 12;5(4):328. doi: 10.1016/j.synbio.2020.10.003. eCollection 2020 Dec.
10
Erratum regarding previously published articles.关于先前发表文章的勘误。
Synth Syst Biotechnol. 2020 Oct 14;5(4):330-331. doi: 10.1016/j.synbio.2020.10.001. eCollection 2020 Dec.
引用本文的文献
1
Effects of renin-angiotensin-aldosterone system inhibitors on disease severity and mortality in patients with COVID-19: A meta-analysis.肾素-血管紧张素-醛固酮系统抑制剂对2019冠状病毒病患者疾病严重程度和死亡率的影响：一项荟萃分析。
J Med Virol. 2021 Apr;93(4):2287-2300. doi: 10.1002/jmv.26695. Epub 2020 Dec 17.
2
Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统抑制剂与因COVID-19住院的高血压患者的死亡风险：系统评价和荟萃分析
Open Heart. 2020 Nov;7(2). doi: 10.1136/openhrt-2020-001353.
本文引用的文献
1
The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.肾素-血管紧张素系统（RAS）阻滞剂对高血压COVID-19患者临床特征的影响。
Ann Transl Med. 2020 Apr;8(7):430. doi: 10.21037/atm.2020.03.229.
Zotero 插件